Abstract:Carbonic anhydrase IX (CA-IX) is a HIF-1-inducible enzyme that is overexpressed in many cancer subtypes to promote survival and invasion in hypoxic niches. Pharmacologic inhibition of CA-DX is achievable through sulfonamide-based inhibitors and has been shown to reduce primary growth of cancers and distant metastasis in preclinical models. We explored a multivalent approach for targeting CA-IX in vivo, noninvasively, with positron emission tomography. Three Ga-68-polyaminocarboxylate chelator complex-conjugated tracers containing one, two, or three 4-(2-aminoethyl)-benzenesulfonamide moieties were synthesized and evaluated for protein binding and imaging properties. Binding affinity to CA-I, -II, -IX, and -XII were determined using a stopped-flow CA catalyzed CO2 hydration assay. Biodistribution and PET/CT imaging were performed using immunocompromised mice bearing CA-IX expressing HT-29 colorectal tumors. Compounds demonstrated good binding affinity to CA-IX (K-i; 7.7-25.4 nM). Ga-68-labeled sulfonamides were obtained in 64-91% decay-corrected average radiochemical yields with 50-536 GBq/mu mol specific activity and >97% average radiochemical purity. All three tracers allowed for the visualization of tumor xenografts at 1 h postinjection, with the monomer displaying the highest contrast. Tumor uptake of the monomer was blockable in the presence of acetazolamide, confirming target specificity. The monomer was excreted predominantly through the kidneys, while the dimer and trimer were cleared by both renal and hepatobiliary pathways. According to biodistribution analysis, tumor uptake (%ID/g) of the monomeric, dimeric, and trimeric tracers were 0.81 +/- 0.15, 1.93 +/- 0.26, and 2.30 +/- 0.53 at 1 h postinjection. This corresponded to tumor-to-muscle ratios of 5.02 +/- 0.22, 4.07 +/- 0.87, and 4.18 +/- 0.84, respectively. Our data suggest that Ga-68-polyaminocarboxylate chelator-conjugated sulfonamides can be used to noninvasively image CA-IX. These CA-IX targeting PET tracers may be used to identify patients who can benefit from treatments targeting this protein or serve as surrogate imaging agents for tumor hypoxia.

Carbonic Anhydrase IX Targeting Mn(II)-Based Magnetic Resonance Molecular Imaging Probe for Hypoxia Tumors

High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX

A novel 111indium-labeled dual carbonic anhydrase 9-targeted probe as a potential SPECT imaging radiotracer for detection of hypoxic colorectal cancer cells

pH‐responsive albumin‐mimetic synthetic nanoprobes for magnetic resonance/fluorescence imaging of thyroid cancer

Preparation and Imaging Study of Tumor-Targeting Mri Contrast Agent Based on Fe3o4 Nanoparticles

Hypoxia-targeting Dendritic MRI Contrast Agent Based on Internally Hydroxy Dendrimer for Tumor Imaging

Inhibition of carbonic anhydrase IX as a novel anticancer mechanism

A metabolic acidity-activatable calcium phosphate probe with fluorescence signal amplification capabilities for non-invasive imaging of tumor malignancy

A Multifunctional Nanotheranostic for the Intelligent MRI Diagnosis and Synergistic Treatment of Hypoxic Tumor.

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

Pet Imaging Of Carbonic Anhydrase Ix Expression Of Ht-29 Tumor Xenograft Mice With Ga-68-Labeled Benzenesulfonamides

A Hexanuclear Gadolinium(III)-Based Nanoprobe for Magnetic Resonance Imaging of Tumor Apoptosis

Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX

Recent Advances in the Development of Molecular Probes for Targeting Carbonic Anhydrases

Fluorine-18 click radiosynthesis and MicroPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX

Bioparameter-directed nanoformulations as MRI CAs enable the specific visualization of hypoxic tumour

Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach

Hypoxia-Responsive Aggregation of Iron Oxide Nanoparticles for T1-to-T2 Switchable Magnetic Resonance Imaging of Tumors

A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC

Imaging of Carbonic Anhydrase IX with an 111In-Labeled Dual-Motif Inhibitor

CA IX-targeted Ag2S Quantum Dots Bioprobe for NIR-II Imaging-guided Hypoxia tumor Chemo-Photothermal Therapy